Efficacy of Urinary Follicle-Stimulating Hormone (FSH) Among Poor Responders
Launched by GERMAN HOSPITAL, ISTANBUL · May 9, 2008
Trial Information
Current as of May 27, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • At least one trial with adequate ovarian stimulation resulted by 4 or less oocytes retrieval.
- Exclusion Criteria:
- • High responder patients
About German Hospital, Istanbul
German Hospital Istanbul is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. Renowned for its state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital actively participates in clinical trials aimed at enhancing patient care and medical innovation. Committed to rigorous scientific standards and ethical practices, German Hospital Istanbul collaborates with international research networks to explore new treatment options and improve health outcomes for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İstanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials